Archive for the ‘ChromaDex Corp. CDXC’ Category

ChromaDex Corp. (CDXC) Announces Supply Agreement with Organic Revolution

Monday, September 26th, 2011

Located in Irvine, California, ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement and pharmaceutical sector. Today, ChromaDex® took a major step towards prominence when they announced a supply partnership with Organic Revolution Worldwide LLC to launch a series of gourmet snacks and grocery items under the Dodo Organics label.

Organic Revolution Worldwide is the first food company to incorporate pTeroPure® into food products. pTeroPure is a proprietary formulation of the naturally occurring antioxidant compound pterostilbene, which is found in blueberries. pTeroPure has the potential to benefit heart health by supporting cholesterol and blood pressure while providing additional benefits related to cognitive function, healthy aging and blood sugar control.

The incorporation of ChromaDex’s pTeroPure® into Organic Revolution’s product line could draw major attention from the sector and lead both companies into the national spotlight. In reference to the supply partnership, Organic Revolution Worldwide CEO David Lewinson stated, “We are delighted to partner with ChromaDex® as we incorporate their revolutionary pTeroPure® pterostilbene into our organic food products under the Dodo Organics label.”

ChromaDex® President William Spengler stated, “Entering the food and beverage market is another key milestone for our company. This partnership creates additional outlets to give consumers access to pTeroPure® and its health benefits in support of a healthy lifestyle.”

Currently, ChromaDex® is trading in the $0.95 range. To learn more about ChromaDex as a whole, visit the company website at: www.ChromaDex.com

Let us hear your thoughts below:

ChromaDex Corp. (CDXC) Provides New Investor Presentation; Outlines Strategy for Accelerated Growth

Tuesday, June 14th, 2011

ChromaDex Corp. announced the release of its new investor presentation. The presentation can be found at www.investors.chromadex.com. Company President William F. Spengler will be presenting this business outlook at the Accredited Members investment conference today at the Hyatt Regency Denver Tech Center in Denver, Colorado.

ChromaDex is implementing four key initiatives to drive growth and increase shareholder value:

• Continuing to grow its legacy business in fine phytochemicals and contract services,
• Fully commercializing pTeroPure® across multiple market channels such as dietary supplement, food & beverage, beauty & personal care, and pharmaceutical markets,
• Aggressively growing revenues associated with BluScience™, the company’s new retail brand which it announced yesterday, as being initially launched at GNC,
• Through science-based leadership in the natural products market, the company will continue developing its existing product pipeline and acquire new proprietary products with intellectual property.

“Bill Spengler will be presenting our strategic plan for growth today,” stated Frank Jaksch Jr., Co-Founder and CEO of ChromaDex, Inc. “This presentation will highlight that the company is at an inflection point in its history and is about to embark on a period of accelerated growth.”

“This plan indicates that the company represents an opportunity for creating value for our shareholders,” added Tom Varvaro, CFO of ChromaDex, Inc. “We are pleased to be able to communicate the company’s direction.”

Let us hear your thoughts below:

ChromaDex Corp. (CDXC) is “One to Watch”

Thursday, March 3rd, 2011

ChromaDex Corp. was established to become the market leader in the creation and supply of botanical reference standards along with related phytochemical products and services. Due to the need for reference standards and other quality assurance methods to identify active substances, drug/compound interactions, and the presence of toxic or adulterating materials, ChromaDex™ provides the tools necessary to help with the quality and control of the market. Listed on the OTC Bulletin Board, ChromaDex Corporation has their headquarters in Irvine, California.

The Company’s primary focus is to create industry-accepted information, products, and services to every layer of the functional food, pharmaceutical, personal care, and dietary supplement markets. They offer the most extensive phytochemical catalog in the world. ChromaDex provides a broad range of analytical services, contract isolation, microbiological, process development, bioassay services, and consulting. These all center on their expertise in natural products. They provide a wide range of services to food, beverage, cosmetic, dietary supplement, and pharmaceutical companies looking for expertise in natural products based services.

ChromaDex is currently focusing on clinical studies and the commercialization of their new product, pTeroPure™ pterostilbene. They received an exclusive worldwide license to all patent rights of pterostilbene from the University of Mississippi and the Agricultural Research Service. The term of the license is up to and including the expiration of various pterostilbene patents held by the licensors.

Pterostilbene has a chemical relation to Resveratrol, a compound found in grapes, blueberries, other small fruits, and the bark of some trees. It is believed that Resveratrol is at least partly responsible for the health benefits attributed to drinking red wine, which include cardiovascular health and cancer prevention.

In September 2010, ChromaDex announced that they initiated a clinical study at The University of Mississippi for pTeroPure™ pterostilbene. The next generation novel ingredient is based on the grant of an exclusive worldwide license to all patent rights of pterostilbene from the University of Mississippi. The clinical trial is being conducted at the UM Medical Center in Jackson, where investigators hope to evaluate the compound in patients with lipid (cholesterol) disorders.

In laboratory tests, pterostilbene has shown promise for improving cardiovascular health, glucose levels, anti-ageing and cognitive function; as well as for possessing cancer-fighting properties. Various scientific publications have shown that pterostilbene has significantly higher activity than resveratrol.

Yesterday, ChromaDex and Bruker Optics Inc., a subsidiary of Bruker Corporation (BRKR), announced a co-development and co-marketing agreement. This agreement will promote a new approach to dietary supplement testing. Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

The collaboration will capitalize on the extensive phytochemical and botanical reference standard capabilities of ChromaDex. It will focus initially on the near infrared spectrometer (NIR) technology created by Bruker Optics. The parties anticipate extending the relationship to include other Bruker analytical technologies. Through this collaboration, a dietary supplement producer will have the opportunity to obtain the in-house capabilities of a contract laboratory without the associated start-up costs.

Let us hear your thoughts below: